poisar

Stocks · News reference

AvePoint Sees Q3 Sales $128.200M-$130.200M vs $133.613M Est

BenzingaBenzinga Newsdesk

AvePoint (NASDAQ:AVPT) sees Q3 sales of $128.200 million-$130.200 million vs $133.613 million analyst estimate.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading